Sort   by:  
 Page size 
MetabolomicsProfiling the metabolome of uterine fluid for early detection of ovarian cancer

Ovarian cancer (OC) causes high mortality in women because of ineffective biomarkers for early diagnosis. Here, we perform metabolomics analysis on an initial training set of uterine fluid from 96 gynecological patients. A seven-metabolite-marker panel consisting of vanillylmandelic acid, norepin...

2023-03-06 | MTBLS4861 | MetaboLights
MetabolomicsSerum lipidomics study looking for specific endometrial polyps biomarkers distinguishing from endometrial cancer or hyperplasia

Endometrial diseases are common gynecological diseases that disorder women of childbearing age and perimenopausal women, including endometrial polyps (EP), endometrial cancer (EC), and endometrial hyperplasia (EH). Clinically, biopsy or imaging methods are usually used to screen and diagnose...

2022-01-14 | MTBLS3444 | MetaboLights
MetabolomicsMulti-omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer
Endometrial cancer (EC) is one of the most common gynecological cancers. Finding biomarkers of EC can support its diagnosis in a non- or minimally-invasive way. In this work, we integrated metabolomics and proteomics for the analysis of multiple types of biosamples to gain a more comprehensive view ...
2022-03-28 | MTBLS3935 | MetaboLights
ProteomicsProteomic analysis of gynecologic cancer tissue
Using iTRAQ technology, we performed shotgun proteomics of gynecological cancer tissues, which tumor cells were captured by laser microdissection to identify biomarker candidate proteins, for gynecological cancer.
ORGANISM(S): Homo sapiens (Human) 
2016-04-27 | PXD001849 | Pride
Ovary Uterus Gynecology Endometrioid High-grade serous 
GenomicsIdentification of differential expression circRNAs profile in Gynecological cancer associated cell lines
Identification of differential expression circRNAs profile in Gynecological cancer associated cell lines
PRJNA1133756 | ENA
MetabolomicsDistinct Cervical Microbiome and Metabolite Profiles Before and After Menopause: Implications for Cervical Cancer Progression

Introduction: Cervical cancer is the fourth most common malignancy in women and is primarily caused by persistent infection with high-risk human papillomavirus (HPV). In addition, host immune responses, genetic factors, and lifestyle habits also have etiological roles. The cervicovaginal microbio...

2025-07-07 | MTBLS12691 | MetaboLights
GenomicsBreast cancer metastasis to gynecological organs – a clinico-pathological and molecular profiling study.
Breast cancer metastasis to gynecological organs – a clinico-pathological and molecular profiling study.
PRJNA473678 | ENA
UnknownSystematic Review: The Impact of Cancer Treatment on the Gut and Vaginal Microbiome in Women With a Gynecological Malignancy.
Not available
S-EPMC5571893 | biostudies-literature
UnknownRacial and ethnic disparities in palliative care utilization among gynecological cancer patients.
Not available
S-EPMC8221248 | biostudies-literature
TranscriptomicsIdentification of differential expression circRNAs profile in Gynecological cancer associated cell lines
Developing a classification model based on differential expression circRNAs profile in cancer cells to improive diagnosis of Gynecological cancer (Cervical cancer:Hela, ovarian cancer: NIHOVCAR3 SKOV3, breast cancer: MCF7, endometrial cancer:RL95-2, normal cell:A293T).
ORGANISM(S): Homo sapiens 
2024-07-13 | GSE271851 | GEO
Sort   by:  
 Page size